logo

Palm Springs fertility clinic bombing: How disaster was averted

CNN21-05-2025

Source: CNN
Christy Holstege, the former mayor of Palm Springs who is 18 weeks pregnant, was playing with her pre-schooler in their living room Saturday morning when a blast reverberated through her neighborhood and a plume of smoke began to grow on the horizon. It didn't take long for word to reach her that the building ablaze was the local fertility clinic.
Panic gripped Holstege as she thought of her last remaining embryo stored inside the clinic and her concern deepened as she considered the safety of the staff that had carried her family through the last five years of in-vitro fertilization treatment – first with her son and again this year.
Through a fortuitous turn of events, the usually bustling American Reproductive Center was completely empty when a car exploded outside the clinic Saturday, blowing a gaping hole in the side of the building and severing the power supply of the lab where thousands of embryos and other specimens are stored.
For miles around the blast zone, Coachella Valley families held the babies and toddlers conceived at ARC. Alongside hopeful would-be parents, they worried for the immediate fate of their remaining embryos in the clinic, and for the long-term safety of the reproductive center, which authorities believe was targeted in an act of domestic terrorism.
Mothers Sophie and Simone Bain-Tohl were hosting a party full of fellow parents when they heard news of the attack. The room grew somber as they surrounded a play mat full of wriggling babies – two of them conceived by IVF – and realized every person in the room either had embryos stored at ARC or knew someone who does.
Though the frozen embryos at the clinic would remain cold without electricity, a set of embryos being incubated would be irreversibly damaged if power was not restored within hours.
But at the scene of the explosion, a firefighter began to hatch a risky plan to protect future families, including that of a fellow first responder.
Firefighters initially rushed to tamp down the blaze caused by the explosion and ensure no victims were inside. But the crumbling building soon began to shift and bomb squad technicians became concerned about a possible secondary device that could put first responders at risk.
When Deputy Fire Chief Greg Lyle arrived an hour after the blast, first responders had been ordered to get out of the still smoking building until a bomb squad could assess the scene.
Clinic director Dr. Maher Abdallah, who was able to access clinic security cameras before the power went out, reported that the embryo lab appeared intact, but Lyle was not convinced. Itching to help, he and the other firefighters began considering how they could ensure the embryo incubators and cryogenic tanks were secure.
'So I went over to the lead FBI investigator, and kind of pitched a crazy scheme to him, fully expecting him to say no,' Lyle said.
The scheme: Lyle would venture alone into the still standing part of the building, which contained unknown risk of structural collapse, a secondary explosion or additional fires, to find the lab and assess the status of the embryos.
'This is a crazy plan, and if anybody's going to get hurt, the only thing that I would be able to be comfortable with is that it would be me,' he said. 'I just had a gut feeling it had to be me.'
The FBI agent, identified by the city police chief as Agent Chris Meltzer, embraced the plan under one condition: Meltzer would accompany Lyle.
Together, the pair headed into the building, cautiously navigating blown-out door frames, crumbling drywall and several inches of standing water, likely from a water main break or fire sprinklers. They eventually spotted a room stacked with what appeared to be cryogenic tanks.
'We thought initially that maybe we could go in and just grab it and go. But it was obvious there was too much (equipment) – too big, too bulky, too heavy,' Lyle said. 'So we determined the only thing we could do would be restore power to this stuff.'
Quickly, they realized the backup generators had failed, and it became increasingly clear they alone would not be able to restore the electricity. The pair picked their way back out of the building to assemble a team of firefighters, police and bomb squad personnel to address the outage.
'It took them a while, but they were successful,' Lyle said.
The team's heroic initiative likely saved the incubating embryos, Abdallah said. An hour or two longer without power could have had tragic consequences.
Unbeknownst to Lyle, the ARC lab houses embryos belonging to the wife of one of his own firefighters, who sent Lyle a message thanking him for preserving his family's future.
'It kind of hit home there. I didn't even know,' Lyle said. The firefighter's wife is among the patients with appointments early this week.
Yet, in order to continue ongoing treatment for patients, it would take a second team effort to keep the delicate process moving forward.
Most Saturdays, Abdallah and his staff are flitting between patient rooms and laboratories, sterilizing equipment, checking on growing embryos and walking hopeful parents through the arduous process of in vitro fertilization.
But through a series of inexplicable events, the clinic was completely empty on Saturday when the car exploded outside.
Abdallah had spontaneously decided to visit family. Two other weekend employees had been called away. And the clinic, just days before, had rescheduled a procedure that would have required 12 employees to be in the office at the time of the explosion.
'So many things happened to protect our staff,' Abdallah said. 'It's just really a miracle.'
Though shaken by the bombing, Abdallah and his staff have been seeking solace in each others' presence and their shared determination to continue operating the clinic.
The attack, though unsuccessful, delivered a seismic shock to patients and violated a space that many feel is far more intimate than just a medical clinic; It's the venue where their families were formed and precious possibilities are stored.
'I went there every week for the last 12 weeks, sometimes twice a week,' Holstege said. 'That is my home, my medical home.'
As the only fertility clinic within a 100-mile radius, ARC stores thousands of embryos, eggs and sperm specimens for patients from Palm Springs to as far as Asia and the Middle East, Abdallah said.
Several families who depend on ARC for fertility services described a profound level of care from the clinic's staff, who have made late-night calls to share test results, scheduled extra ultrasounds for nervous mothers and held patients in their arms during moments of both grief and joy.
'ARC is a place where we went to build our family and holds so much more than just a clinic. It's a place of vulnerability and hope and tenderness, and the staff there is just incredible,' said Sophie Bain-Tohl, whose four-month-old son was conceived at ARC.
Though Bain-Tohl and her wife plan to keep their embryos at ARC, the attack has left them with a lingering fear for the safety of their embryos, which they hope will one day provide them with a daughter.
'Our sense of safety is shattered by something like this,' Simone Bain-Tohl said. 'It's such an absurd event that you never really think it's going to happen, especially to a place that's tied to so much hope and vulnerability.'
Investigators say the 25-year-old bombing suspect, who was killed in the blast, had 'nihilistic ideations' and intentionally targeted the IVF facility – a reality that Holstege and other patients are having difficulty coming to terms with.
'Why would someone do this? Who could do this? This is a place of hope and creating life,' said Holstege.
For some patients with appointments in the days following the explosion, halting treatment is simply not an option, Abdallah explained. The window for egg retrieval and embryo transfer is very tight and delaying care would mean starting the entire process over again – risking time and money many couples do not have.
Less than 24 hours after the bombing, Abdallah was formulating a plan to continue providing time-sensitive treatment to these patients, which required retrieving their valuable medical records from inside the most heavily damaged part of the clinic.
Again, a crew of fire personnel and other law enforcement entered the compromised building.
'We needed a team of people to kind of bucket brigade all these folders out of the building,' Lyle said. Abdallah also asked them to haul out two brand new ultrasound machines.
'I was just really amazed at the risk they're willing to take, and how they just work so well together,' the clinic director said.
As the clinic races to rebuild, Abdallah is determined to continue providing care. On Monday, his staff saw patients in a room loaned to them by a fellow physician.
But the emotional trauma experienced by his patients and staff is not lost on Abdallah, whose office is holding a news conference Thursday to update the community on its plans for 'moving forward with strength and renewed purpose.'
'The patients who have embryos, a lot of them regard those embryos as children,' he said. 'They go through so much to get to that point where their embryos are frozen. They need a lot of reassurance to know that their embryos are safe.'
See Full Web Article

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tool Predicts if Seniors with Cancer Can Stay Home Post Op
Tool Predicts if Seniors with Cancer Can Stay Home Post Op

Medscape

time41 minutes ago

  • Medscape

Tool Predicts if Seniors with Cancer Can Stay Home Post Op

TOPLINE: A novel predictive model named STAYHOME effectively estimated the risk of losing the ability to live at home among older adults after cancer surgery, demonstrating good calibration with minimal deviation from observed risks. The model predicted a 2.4% and 3.4% risk for admission to a nursing home at 6 months and 12 months, respectively. METHODOLOGY: Older adults prioritize long-term functional independence, and the ability to return and stay at home after cancer surgery remains a key concern. However, current prognostic tools focus on short-term outcomes, lacking individualized long-term risk estimates. To estimate the risk of losing the ability to live at home post-surgery, researchers developed and internally validated a risk prediction model, named STAYHOME, among 97,353 community-dwelling older adults (median age, 76 years) who underwent cancer surgery between 2007 and 2019. The predictive model included preoperative variables such as age, sex, rural residence, previous cancer diagnosis, surgery type, frailty, receipt of home care support, receipt of neoadjuvant therapy, cancer site, and cancer stage. The primary outcome was the inability to stay at home after cancer surgery, defined as the time to admission to a nursing home, and was measured at 6 months and 12 months. TAKEAWAY: Overall, 2658 patients (2.7%) at 6 months and 3746 (3.8%) at 12 months were admitted to a nursing home post-surgery. The mean predicted risk of not staying home was 2.4% at 6 months and 3.4% at 12 months. The STAYHOME tool demonstrated a strong predictive capability, with areas under the curve of 0.76 and 0.75 for 6- and 12-month predictions, respectively. The tool also demonstrated minimal deviation from the observed risk for 6-month (0.33 percentage point on average; calibration slope, 1.27) and 12-month (0.46 percentage point on average; calibration slope, 1.17) predictions. The model's calibration was excellent for most predictors at 6 months and 12 months, with a deviation of < 0.8 percentage points from the observed probability; only age older than 85 years (1.13%), preoperative frailty (1.16%), and receipt of preoperative home care support (1.25%) exceeded the deviation of 1 percentage point at 12 months. Across risk deciles, deviations between predicted and observed probabilities were 0.1%-1.5% at 6 months and 0.1%-1.9% at 12 months, reflecting good calibration. The deviation for the slight overestimation at or above the seventh decile remained under 2% for both timepoints. IN PRACTICE: 'The STAYHOME tool demonstrated good discrimination and was well calibrated. Thus, it may be a useful tool to identify a specific group of individuals at risk of not remaining home,' the authors wrote. '[The tool] used information readily available to patients, care partners, and healthcare professionals and may be implemented to provide them with individualized risk estimates and improve surgical oncology care delivery and experience for older adults,' they concluded. SOURCE: This study, led by Julie Hallet, MD, Odette Cancer Centre, Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, was published online in JAMA Surgery. LIMITATIONS: The STAYHOME tool showed slightly reduced discrimination for predictor levels of preoperative frailty, preoperative home care use, receipt of neoadjuvant therapy, and having stage IV disease. The model was also less well calibrated at the extremes of the risk distribution, with a slight overestimation in higher-risk categories. DISCLOSURES: This study was funded by operating grants from the Canadian Institutes for Health Research, Ontario Cancer Research Institute, and ICES. One author reported receiving speaker fees from Ipsen, outside the submitted work. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care
Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

Associated Press

timean hour ago

  • Associated Press

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

NEW YORK, June 30, 2025 /PRNewswire/ -- For individuals managing respiratory conditions, every breath matters—and so does the freedom to move, explore, and live life on their own terms. At VARON, that belief is at the heart of everything we do. With our trusted line of portable oxygen concentrators, VARON continues to empower users across the globe with the freedom to breathe easier—wherever life takes them. Built on years of research, real-world feedback, and engineering excellence, VARON's portable oxygen concentrators—the VP-2 and VP-6 —remain leading choices for patients seeking mobility without compromise. These machines are not just reliable tools for supplemental oxygen—they're symbols of independence, quality, and care. 'Oxygen therapy should be a bridge to more freedom, not more restrictions,' said a VARON CEO. 'That's why our focus has always been on designing dependable, travel-ready solutions that reflect how people actually live their lives.' Trusted Performance for Life in Motion From day trips and errands to cross-country travel and everything in between, the VP series is built to move with users—not slow them down. These devices have earned a strong reputation among long-term users for their balance of performance, portability, and ease of use. The VP-6: Continuous Flow Power in a Portable Frame One of the most versatile options in its class, the VP-6 continuous portable oxygen concentrator delivers continuous flow oxygen in a compact, travel-friendly form—making it a perfect fit for patients who prefer the exprerience of continuous oxygen supply. It also features a replaceable rechargeable battery, timer settings, remote control, and even a nebulizer function, ensuring it's equipped for a wide range of daily and emergency scenarios. Trusted by users for its stability and versatility, the VP-6 continues to be a top choice for those who demand oxygen support without sacrificing freedom. The VP-2: Lightweight, Reliable, and Ready to Go The VP-2 pulse flow oxygen concentrator is ideal for users with active lifestyles who require oxygen support in a lighter, more compact format. This pulse dose concentrator weighs just a few pounds, yet delivers consistently responsive oxygen therapy that adjusts to the user's breathing rhythm. With long battery life, intuitive controls, and quiet performance, the VP-2 remains a go-to device for travel, social activities, and everyday movement. Why VARON Stands Out What sets VARON apart isn't just its devices—but the philosophy behind them. VARON engineers its products with the real-life needs of users in mind—putting equal weight on comfort, confidence, and care. Both the VP-2 and VP-6 portable oxygen concentrator reflect VARON's commitment to: Every detail, from power efficiency to button placement, is shaped by VARON's mission to make oxygen therapy more accessible and more empowering. Why VARON Stands Out Mobility doesn't stop at the device. VARON's comprehensive line of accessories and replacement parts like spare batteries, replacement filters, cannulas, and make the experience more seamless, and help users stay prepared and protected whether they are heading to the grocery store or crossing state lines. Proven by Experience, Driven by Purpose VP-2 and VP-6 portable oxygen concentrator users regularly share how VARON technology has transformed their daily lives—from regaining the confidence to travel, to joining family gatherings without anxiety, to simply stepping outside for a walk. These stories are what inspire our team every day. Backed by years of trusted performance and a drive to innovate, VARON continues to improve the experience of portable oxygen therapy. About VARON VARON is a leading name in respiratory care, known for its innovation in portable and home-use oxygen concentrators. With a deep focus on mobility, user comfort, and dependable performance, VARON helps users around the world live fully—without letting respiratory challenges define their boundaries. Live freely. Breathe fully. Go with VARON. MEDIA CONTACT: VARON Oxygen Solutions Email: [email protected] Website: View original content to download multimedia: SOURCE Varon oxygen concentrator

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care
Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

Yahoo

timean hour ago

  • Yahoo

Enhancing Mobility and Independence: VARON Oxygen Concentrators Deliver a New Standard of Freedom and Care

NEW YORK, June 30, 2025 /PRNewswire/ -- For individuals managing respiratory conditions, every breath matters—and so does the freedom to move, explore, and live life on their own terms. At VARON, that belief is at the heart of everything we do. With our trusted line of portable oxygen concentrators, VARON continues to empower users across the globe with the freedom to breathe easier—wherever life takes them. Built on years of research, real-world feedback, and engineering excellence, VARON's portable oxygen concentrators—the VP-2 and VP-6—remain leading choices for patients seeking mobility without compromise. These machines are not just reliable tools for supplemental oxygen—they're symbols of independence, quality, and care. "Oxygen therapy should be a bridge to more freedom, not more restrictions," said a VARON CEO. "That's why our focus has always been on designing dependable, travel-ready solutions that reflect how people actually live their lives." Trusted Performance for Life in Motion From day trips and errands to cross-country travel and everything in between, the VP series is built to move with users—not slow them down. These devices have earned a strong reputation among long-term users for their balance of performance, portability, and ease of use. The VP-6: Continuous Flow Power in a Portable Frame One of the most versatile options in its class, the VP-6 continuous portable oxygen concentrator delivers continuous flow oxygen in a compact, travel-friendly form—making it a perfect fit for patients who prefer the exprerience of continuous oxygen supply. It also features a replaceable rechargeable battery, timer settings, remote control, and even a nebulizer function, ensuring it's equipped for a wide range of daily and emergency scenarios. Trusted by users for its stability and versatility, the VP-6 continues to be a top choice for those who demand oxygen support without sacrificing freedom. The VP-2: Lightweight, Reliable, and Ready to Go The VP-2 pulse flow oxygen concentrator is ideal for users with active lifestyles who require oxygen support in a lighter, more compact format. This pulse dose concentrator weighs just a few pounds, yet delivers consistently responsive oxygen therapy that adjusts to the user's breathing rhythm. With long battery life, intuitive controls, and quiet performance, the VP-2 remains a go-to device for travel, social activities, and everyday movement. Why VARON Stands Out What sets VARON apart isn't just its devices—but the philosophy behind them. VARON engineers its products with the real-life needs of users in mind—putting equal weight on comfort, confidence, and care. Both the VP-2 and VP-6 portable oxygen concentrator reflect VARON's commitment to: Smart, responsive oxygen delivery Reliable battery solutions and power options Quiet, discreet operation for comfort in public spaces Lightweight builds and ergonomic designs Simple interfaces, suited for users of all ages Every detail, from power efficiency to button placement, is shaped by VARON's mission to make oxygen therapy more accessible and more empowering. Why VARON Stands Out Mobility doesn't stop at the device. VARON's comprehensive line of accessories and replacement parts like spare batteries, replacement filters, cannulas, and make the experience more seamless, and help users stay prepared and protected whether they are heading to the grocery store or crossing state lines. Proven by Experience, Driven by Purpose VP-2 and VP-6 portable oxygen concentrator users regularly share how VARON technology has transformed their daily lives—from regaining the confidence to travel, to joining family gatherings without anxiety, to simply stepping outside for a walk. These stories are what inspire our team every day. Backed by years of trusted performance and a drive to innovate, VARON continues to improve the experience of portable oxygen therapy. About VARON VARON is a leading name in respiratory care, known for its innovation in portable and home-use oxygen concentrators. With a deep focus on mobility, user comfort, and dependable performance, VARON helps users around the world live fully—without letting respiratory challenges define their boundaries. Live freely. Breathe fully. Go with VARON. MEDIA CONTACT: VARON Oxygen SolutionsEmail: official@ View original content to download multimedia: SOURCE Varon oxygen concentrator Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store